VERVE-102
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| VERVE-102 for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VERVE-102 for coronary artery disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| VERVE-102 for hypercholesterolemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VERVE-102 for hyperlipoproteinemia type ii | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VERVE-102 for myocardial infarction | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |